# EDGAR Filing Document

**Accession Number:** 0001679628
**File Stem:** 0001493152-23-004048
**Filing Date:** 2023-2
**Character Count:** 1997
**Document Hash:** 7e76e4ffa9ae96661c8c9ff074ad4a8f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-004048.hdr.sgml**: 20241210

**ACCESSION NUMBER**: 0001493152-23-004048

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230209

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JUPITER NEUROSCIENCES, INC.
- **CENTRAL INDEX KEY:** 0001679628
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **IRS NUMBER:** 474828381
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1001 NORTH US HWY 1
- **STREET 2:** SUITE 504
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33477
- **BUSINESS PHONE:** (561) 406-6154

**MAIL ADDRESS:**
- **STREET 1:** 1001 NORTH US HWY 1
- **STREET 2:** SUITE 504
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33477

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Jupiter Orphan Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20160713

**Jupiter Neurosciences, Inc.**

1001 North US HWY 1, Suite 504

Jupiter, Florida 33477

February 9, 2023

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | Jupiter Neurosciences, Inc. |
|  | Registration Statement on Form S-1 |
|  | CIK No. 0001679628 |
|  | File No. 333-260183 |

---

Ladies and Gentlemen:

In accordance with Rule 461 of the Securities Act of 1933, as amended, Jupiter Neurosciences, Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on Monday, February 13, 2023, or as soon thereafter as possible.

\* \* \* \*

Very Truly Yours,

---

| |
|:---|
| **Jupiter Neurosciences, Inc.** |
| */s/ Christer Rosén* |
| Christer Rosén |
| Chief Executive Officer |

---